Consensus Statement: Chromosomal Microarray Is a First-Tier Clinical Diagnostic Test for Individuals with Developmental Disabilities or Congenital Anomalies
David T. Miller, Margaret P Adam, Swaroop Aradhya et al. · The American Journal of Human Genetics · 2010
Chromosomal microarray (CMA) is increasingly utilized for genetic testing of individuals with unexplained developmental delay/intellectual disability (DD/ID), autism spectrum disorders (ASD), or multiple congenital anomalies (MCA). Performing CMA and G-banded karyotyping on every patient substantially increases the total cost of genetic testing. The International Standard Cytogenomic Array (ISCA) Consortium held two international workshops and conducted a literature review of 33 studies, including 21,698 patients tested by CMA. We provide an evidence-based summary of clinical cytogenetic testing comparing CMA to G-banded karyotyping with respect to technical advantages and limitations, diagnostic yield for various types of chromosomal aberrations, and issues that affect test interpretation. CMA offers a much higher diagnostic yield (15%-20%) for genetic testing of individuals with unexplained DD/ID, ASD, or MCA than a G-banded karyotype ( approximately 3%, excluding Down syndrome and other recognizable chromosomal syndromes), primarily because of its higher sensitivity for submicroscopic deletions and duplications. Truly balanced rearrangements and low-level mosaicism are generally not detectable by arrays, but these are relatively infrequent causes of abnormal phenotypes in this population (<1%). Available evidence strongly supports the use of CMA in place of G-banded karyotyping as the first-tier cytogenetic diagnostic test for patients with DD/ID, ASD, or MCA. G-banded karyotype analysis should be reserved for patients with obvious chromosomal syndromes (e.g., Down syndrome), a family history of chromosomal rearrangement, or a history of multiple miscarriages.
Cited by 2,883 works. doi:10.1016/j.ajhg.2010.04.006 Open-access PDF
Authors
- David T. Miller
- Margaret P Adam
- Swaroop Aradhya
- Leslie G. Biesecker
- Arthur R. Brothman
- Nigel P. Carter
- Deanna M. Church
- John Anthony Crolla
- Evan E. Eichler
- Charles J. Epstein
- W. Andrew Faucett
- Lars Feuk
- Jan M. Friedman
- Ada Hamosh
- Laird Jackson
- Erin B. Kaminsky
- Klaas Kok
- Ian D. Krantz
- Robert M. Kuhn
- Charles Lee
References
- Global variation in copy number in the human genome
- ISCN 1995 An international system for human cytogenetic nomenclature
- Structural variation in the human genome
- Origins and functional impact of copy number variation in the human genome
- 22q11.21 Deletion Syndromes: A Review of Proximal, Central, and Distal Deletions and Their Associated Features
- Large recurrent microdeletions associated with schizophrenia
- Association between Microdeletion and Microduplication at 16p11.2 and Autism
- Integrated detection and population-genetic analysis of SNPs and copy number variation
- Structural Variation of Chromosomes in Autism Spectrum Disorder
- DECIPHER: Database of Chromosomal Imbalance and Phenotype in Humans Using Ensembl Resources